LegalJun 26, 2026, 04:11 PM
Genenta Science wins on voting rights, appeals corporate purpose suspension
AI Summary
Genenta Science S.p.A. announced that the Court of Milan issued an interim order in a proceeding initiated by minority shareholders. The Court denied the request to suspend the multiple voting rights mechanism, which remains in effect. However, the Court granted the request to suspend the resolution amending the company's corporate purpose, citing concerns about its breadth. Genenta Science has appealed the suspension of the corporate purpose resolution, with a hearing scheduled for July 9, 2026.
Key Highlights
- Court of Milan issued an interim order regarding two shareholder resolutions.
- Denied request to suspend the May 2, 2024 resolution on multiple voting rights mechanism.
- Multiple voting rights mechanism remains in effect, with no findings of unlawful conduct.
- Granted request to suspend the October 29, 2025 resolution amending the corporate purpose.
- Suspension of corporate purpose resolution is pending further proceedings, but does not invalidate prior transactions.
- Genenta Science filed a precautionary appeal on June 22, 2026, against the corporate purpose suspension.
- Appeal hearing before the Court of Milan is scheduled for July 9, 2026.
Price Impact
More from GNTA